Investing

Biogen : BIIB

BIIB

Stock Data

$206.71

$0.43 (0.21%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Biogen Inc. is a pioneer in the biotechnology sector, focusing on developing treatments for neurological and neurodegenerative conditions. With a global presence, Biogen offers a range of therapies for diseases such as multiple sclerosis, spinal muscular atrophy, and Alzheimer's. Its portfolio includes well-known drugs like TECFIDERA, SPINRAZA, and ADUHELM. Additionally, Biogen is involved in creating biosimilars, which are essentially generic versions of biologic drugs, expanding its impact on healthcare. Founded in 1978 and based in Cambridge, Massachusetts, Biogen continues to push the boundaries of medicine through innovation and partnerships.

Latest Activity

BIIBBiogen Inc.

Reports Wed Jul 29Before openConfirmed

Jul 29, 9:00am ET

Biogen reports before the bell with Leqembi momentum on the line against shrinking MS royalties, the test of whether its Alzheimer's bet can actually move the needle on growth.

ShareRead more

BIIBBiogen

Q2 2026

Jul 29, 6:10am ET

EPS

$3.60

est $2.07+73.6%

Revenue

$2.74B

est $2.46B+11.4%

Biogen's growth portfolio revenue finally surpassed its legacy MS business, propelled by a massive 73% EPS beat and momentum from the Apellis acquisition, prompting a $0.60 full-year guidance raise.

ShareRead more

All Biogen Articles

607 Articles

Danielle Liverance | Jul 10, 2026 at 3:37 PM EDT

Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up

A Phase 3 trial failure has erased a year of gains for Ionis Pharmaceuticals in just days, and the ripple…

David Moadel | Apr 22, 2026 at 10:27 AM EDT

UBS Upgrades Biogen to Buy With a $225 Target: Are the Next 12 Months a Pipeline Catalyst Parade?

Biogen (NASDAQ:BIIB | BIIB Price Prediction) picked up a strong endorsement from Wall Street on Wednesday, as UBS analyst Michael…

Lee Jackson | Apr 22, 2026 at 7:58 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Biogen, Cava Group, GitLab, Halliburton, Qualcomm, Seagate, Toast, and More

Pre-Market Stock Futures: Futures are trading higher as we hit the midweek point. All major indices finished lower on Tuesday…

David Moadel | Apr 20, 2026 at 11:26 AM EDT

Wells Fargo Upgrades Biogen to Overweight: Does the Alzheimer’s Story Finally Have a Second Act?

Biogen (NASDAQ:BIIB | BIIB Price Prediction) stock just earned a strong endorsement from Wells Fargo on Monday, as analyst Mohit…

Lee Jackson | Apr 14, 2026 at 7:58 AM EDT

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Biogen, Birkenstock, Fastly, Ford, Lennox International, Netskope, SanDisk, Tesla, and More

Pre-Market Stock Futures: The futures are trading mixed this morning, after what started as another week of the same old…

Austin Smith | Mar 11, 2026 at 12:37 PM EDT

Josh Brown: Biotech growth stocks immune to disruption risk

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap biotech:…

Lee Jackson | Dec 10, 2025 at 8:09 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More

Pre-Market Stock Futures: Futures are trading modestly lower as the big day has finally arrived: the Federal Reserve will wrap…

Lee Jackson | Nov 6, 2025 at 8:02 AM EST

Here Are Thursday’s Top Wall Street Analysts Research Calls: Amazon.com, Biogen, Caterpillar, e.l.f. Beauty, Southern Company and More

Pre-Market Futures: The futures are trading modestly higher on Thursday after a big snap-back rally on Wednesday, as all the…

Will Ashworth | Mar 17, 2025 at 3:01 PM EDT

Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 Stocks 

If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t…

Ian Cooper | Mar 10, 2025 at 12:47 PM EDT

The Nasdaq is Cratering But REGN, BIIB and CSGP Are Up Big Today

Markets are tanking on tariff fears, inflationary concerns and now fears of recession. “Given this is so uncertain and that…

Trey Thoelcke | Feb 5, 2025 at 8:45 AM EST

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big…

Rich Duprey | Jan 21, 2025 at 7:30 AM EST

Billionaire Sells Palantir Stock and Buys This Stock That Could Soar 64% According to a Wall Street Expert

Billionaire investor Ken Griffin is the founder of Citadel Advisors, one of the world’s most successful alternative investment firms. With…

Rich Duprey | Oct 31, 2024 at 9:30 AM EDT

Prediction: Vertex Pharmaceuticals (VRTX) Could Be The Next Stock Split Stock

Companies announce stock splits all the time, and so far this year a number of high profile companies have divvied…

John Seetoo | Mar 15, 2024 at 9:11 AM EDT

$10 Biotech Stock Wall Street Says Will Be Up Over 200% This Year

Dementia is a major healthcare problem across the globe. It is estimated by medical professionals that someone develops some form…

Lee Jackson | Jul 28, 2023 at 8:52 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: Apple, Boeing, Carvana, Coty, Meta, RTX, Southwest Airlines, SunPower and More

Friday's top analyst upgrades and downgrades included Apple, Bilibili, Boeing, Carvana, Coty, Estee Lauder, Meta Platforms, Omega Healthcare Investors, RTX,…